138 related articles for article (PubMed ID: 1485649)
1. Evidence of a common regulation of IgE and IgG-subclass antibodies in humans during immunotherapy.
Søndergaard I; Poulsen LK; Osterballe O; Weeke B
Allergy; 1992 Oct; 47(5):467-70. PubMed ID: 1485649
[TBL] [Abstract][Full Text] [Related]
2. A computational approach to the description of individual immune responses. IgE and IgG-subclass allergen-specific antibodies formed during immunotherapy.
Søndergaard I; Poulsen LK; Osterballe O; Weeke B
Allergy; 1991 Jan; 46(1):10-9. PubMed ID: 2018204
[TBL] [Abstract][Full Text] [Related]
3. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.
Djurup R; Malling HJ; Søndergaard I; Weeke B
J Allergy Clin Immunol; 1985 Jul; 76(1):46-55. PubMed ID: 4008813
[TBL] [Abstract][Full Text] [Related]
4. IgG subclass antibody markers in grass pollen immunotherapy.
Moss RB
N Engl Reg Allergy Proc; 1987; 8(6):409-15. PubMed ID: 3325818
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
6. Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies.
Batard T; Basuyaux B; Laroze A; Lambin P; Brémard-Oury C; Aucouturier P; Hamilton RG; David B; Peltre G
Int Arch Allergy Immunol; 1993; 102(3):279-87. PubMed ID: 8219781
[TBL] [Abstract][Full Text] [Related]
7. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy.
Djurup R; Osterballe O
Allergy; 1984 Aug; 39(6):433-41. PubMed ID: 6496881
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium.
Malling HJ; Djurup R
Allergy; 1988 Jan; 43(1):60-70. PubMed ID: 3344936
[TBL] [Abstract][Full Text] [Related]
9. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy.
Djurup R
Allergy; 1985 Oct; 40(7):469-86. PubMed ID: 3907393
[TBL] [Abstract][Full Text] [Related]
10. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
12. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
[TBL] [Abstract][Full Text] [Related]
13. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the epitope recognition profiles of IgE, IgG1, and IgG4 during birch pollen immunotherapy.
Gepp B; Lengger N; Möbs C; Pfützner W; Radauer C; Bohle B; Breiteneder H
J Allergy Clin Immunol; 2016 May; 137(5):1600-1603.e1. PubMed ID: 26686470
[No Abstract] [Full Text] [Related]
15. Effect of hyposensitization for tree pollinosis on associated apple allergy.
Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L
J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432
[TBL] [Abstract][Full Text] [Related]
16. Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.
Roberts AM; Van Ree R; Cardy SM; Bevan LJ; Walker MR
Immunology; 1992 Jul; 76(3):389-96. PubMed ID: 1526648
[TBL] [Abstract][Full Text] [Related]
17. Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy.
Peng ZK; Naclerio RM; Norman PS; Adkinson NF
J Allergy Clin Immunol; 1992 Feb; 89(2):519-29. PubMed ID: 1740582
[TBL] [Abstract][Full Text] [Related]
18. IgG subclass antibody response to hymenoptera venom.
Pastorello EA; Incorvaia C; Vassellatti D; Qualizza R; Codecasa LR
N Engl Reg Allergy Proc; 1987; 8(6):437-41. PubMed ID: 3325820
[TBL] [Abstract][Full Text] [Related]
19. Characterization of grass pollen-specific IgE, IgA, IgM classes and IgG subclasses in allergic patients.
Desvaux FX; Peltre G; David B
Int Arch Allergy Appl Immunol; 1989; 89(2-3):281-7. PubMed ID: 2759718
[TBL] [Abstract][Full Text] [Related]
20. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
